Connor Clark & Lunn Investment Management Ltd. lifted its position in CareTrust REIT, Inc. (NASDAQ:CTRE – Free Report) by 114.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 77,231 shares of the real estate investment trust’s stock after acquiring an additional 41,272 shares during the period. Connor Clark & Lunn Investment Management Ltd.’s holdings in CareTrust REIT were worth $2,089,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. JPMorgan Chase & Co. increased its position in shares of CareTrust REIT by 381.2% in the third quarter. JPMorgan Chase & Co. now owns 6,878,379 shares of the real estate investment trust’s stock worth $212,267,000 after acquiring an additional 5,448,904 shares in the last quarter. Eagle Asset Management Inc. grew its position in CareTrust REIT by 22.4% during the third quarter. Eagle Asset Management Inc. now owns 428,699 shares of the real estate investment trust’s stock valued at $13,264,000 after purchasing an additional 78,560 shares in the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. purchased a new position in CareTrust REIT during the third quarter valued at approximately $7,475,000. Geode Capital Management LLC grew its position in CareTrust REIT by 7.4% during the third quarter. Geode Capital Management LLC now owns 3,732,609 shares of the real estate investment trust’s stock valued at $115,209,000 after purchasing an additional 258,271 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its position in CareTrust REIT by 5.3% during the fourth quarter. Bank of New York Mellon Corp now owns 2,505,883 shares of the real estate investment trust’s stock valued at $67,784,000 after purchasing an additional 126,280 shares in the last quarter. 87.77% of the stock is owned by hedge funds and other institutional investors.
CareTrust REIT Price Performance
NASDAQ CTRE opened at $28.89 on Wednesday. The company has a quick ratio of 3.82, a current ratio of 3.82 and a debt-to-equity ratio of 0.14. The stock has a market capitalization of $5.42 billion, a PE ratio of 36.57, a price-to-earnings-growth ratio of 1.25 and a beta of 1.11. The company has a 50 day moving average price of $26.52 and a two-hundred day moving average price of $28.65. CareTrust REIT, Inc. has a 12-month low of $23.26 and a 12-month high of $33.15.
CareTrust REIT Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Monday, March 31st will be paid a $0.335 dividend. This represents a $1.34 dividend on an annualized basis and a dividend yield of 4.64%. This is a boost from CareTrust REIT’s previous quarterly dividend of $0.29. CareTrust REIT’s payout ratio is presently 146.84%.
Analyst Upgrades and Downgrades
A number of research analysts recently commented on CTRE shares. Deutsche Bank Aktiengesellschaft raised shares of CareTrust REIT from a “hold” rating to a “buy” rating and set a $31.00 price objective on the stock in a research report on Thursday, March 13th. Wedbush reaffirmed an “underperform” rating and set a $26.00 price objective on shares of CareTrust REIT in a research report on Friday, March 14th. Wells Fargo & Company lowered their price objective on shares of CareTrust REIT from $34.00 to $31.00 and set an “overweight” rating on the stock in a research report on Monday, March 10th. BMO Capital Markets downgraded shares of CareTrust REIT from an “outperform” rating to a “market perform” rating and lowered their price objective for the company from $34.00 to $32.00 in a research report on Monday, December 9th. Finally, Royal Bank of Canada lowered their price objective on shares of CareTrust REIT from $37.00 to $32.00 and set an “outperform” rating on the stock in a research report on Friday, February 21st. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $31.00.
Read Our Latest Stock Report on CareTrust REIT
CareTrust REIT Profile
CareTrust REIT, Inc’s (CareTrust REIT or the Company) primary business consists of acquiring, financing, developing and owning real property to be leased to third-party tenants in the healthcare sector. As of March 31, 2024, the Company owned directly or through a joint venture and leased to independent operators, 228 skilled nursing facilities (SNFs), multi-service campuses, assisted living facilities (ALFs) and independent living facilities (ILFs) consisting of 24,189 operational beds and units located in 29 states with the highest concentration of properties by rental income located in California and Texas.
Featured Stories
- Five stocks we like better than CareTrust REIT
- Trading Halts Explained
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Best Aerospace Stocks Investing
- 3 Must-Own Stocks to Build Wealth This Decade
- How to Invest in Insurance Companies: A Guide
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Want to see what other hedge funds are holding CTRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CareTrust REIT, Inc. (NASDAQ:CTRE – Free Report).
Receive News & Ratings for CareTrust REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareTrust REIT and related companies with MarketBeat.com's FREE daily email newsletter.